|
|
||||||||
Nephrology Research Unit and Departments of Medicine and Anesthesiology, Mayo Clinic/Foundation, Rochester; and University of Minnesota, Minneapolis, Minnesota 55905
In the glycerol model of renal injury we describe an acute rise
in systemic arterial pressure which is attended by a reduced vasodilatory response to acetylcholine in vivo; vasodilatory responses to verapamil, however, were not impaired. Neither arginine nor sodium
nitroprusside diminished this rise in blood pressure;
N
-nitro-L-arginine methyl ester
(L-NAME) elevated
basal mean arterial pressure and markedly blunted the rise in mean
arterial pressure following the administration of glycerol. Aortic
rings from the glycerol-treated rat demonstrate an impaired
vasodilatory response to acetylcholine, an effect not repaired by
arginine; the vasodilatory responses to nitric oxide donors, sodium
nitroprusside and SIN-1, were also impaired; 8-bromo-cGMP,
at higher doses, evinced a vasodilatory response comparable to that
observed in the control rings. This pattern of responses was not a
nonspecific effect of aortic injury, since aortic rings treated with
mercuric chloride, a potent oxidant, displayed an impaired vasodilatory
response to acetylcholine but not to sodium nitroprusside. We conclude
that in the glycerol model of heme protein-induced tissue injury, there
is an acute elevation in mean arterial pressure attended by impaired
endothelium-dependent vasodilatation in vitro and in vivo. We suggest
that the acute scavenging of nitric oxide by heme proteins depletes the
blood vessel wall of its endogenous vasodilator and permeation of heme proteins into the blood vessel wall may contribute to such sustained effects as observed in vitro.
nitric oxide; vasoconstriction; rhabdomyolysis
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |